Please assess the completion status of the following clinical trial:

Trial Title: Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients with multi-vessel coronary artery disease (CAD) amenable to hybrid revascularization and fulfilling the following criteria:~1. ≥70% left-anterior descendent (LAD) obstruction suitable for surgical revascularization using the left internal mammary artery (LIMA);~2. patients amenable to a off-pump beating heart revascularization procedure;~3. non-LAD coronary lesions suitable for percutaneous coronary artery intervention (PCI), as adjudicated by one interventional cardiologist and one cardiac surgeon;~4. ≥ 70 years of age~5. Written informed consent for the use of personal data~Exclusion Criteria:~1. patients hemodynamically unstable;~2. acute or recent (\< 1 month) myocardial infarction;~3. severe heart failure (NYHA Class IV);~4. creatinine \> 2.2 mg/dl;~5. allergy to radiographic contrast;~6. contraindication to double antiaggregation therapy (DAT) for at least 12 months;~7. previous cardiac surgery of any type;~8. previous thoracic surgery involving left pleural space;~9. previous coronary stenting: within one month for BMS, within 6 months for DES;~10. disabling stroke within previous 6 months;~11. need for concomitant cardiac surgery during index hospitalization;

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hybrid group (Type: None): Patients with multi-vessel coronary artery disease (CAD) amenable to hybrid revascularization (LIMA-LAD surgical revascularization followed by PCI)

Based on this trial design, predict the completion outcome and termination type (if applicable).